Literature DB >> 30479475

Matrix metalloproteinases in ureteropelvic junction obstruction.

A Pavlaki1, N Printza1, E Farmaki1, S Stabouli1, A Taparkou1, J Dotis1, F Papachristou1.   

Abstract

BACKGROUND: Management of ureteropelvic junction obstruction (UPJO) remains controversial. The aim of the present study was to measure the levels of matrix metalloproteinases (MMPs) in UPJO patients who were planned to undergo surgery and thus clarify if MMPs levels could serve as potential biomarkers of surgical obstruction in UPJO.
METHODS: Serum samples of infants with UPJO diagnosis were compared to serum samples of healthy age-matched controls. MMP2 and MMP9 were quantified using enzyme-linked immunosorbent assay (ELISA).
RESULTS: A total of 17 infants with UPJO diagnosis, and median age 1.5 months, were prospectively recruited. MMP9 levels were significantly decreased in the serum samples of UPJO infants compared to controls (p =0.037). Also MMP2 values were higher in UPJO infants compared to controls, but the difference was not statistically significant (p =0.206).
CONCLUSIONS: This study found decreased concentrations of MMP9 in infants with obstructive hydronephrosis. However, the results should be tested in larger population samples and even be evaluated simultaneously with urine samples in order to delineate the ability of MMPs to serve as obstruction biomarkers. HIPPOKRATIA 2017, 21(3): 136-139.

Entities:  

Keywords:  MMP2; MMP9; Matrix metalloproteinases; biomarkers; infants; ureteropelvic junction obstruction

Year:  2017        PMID: 30479475      PMCID: PMC6247996     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  20 in total

Review 1.  Role of matrix metalloproteinases in renal pathophysiologies.

Authors:  J M Catania; G Chen; A R Parrish
Journal:  Am J Physiol Renal Physiol       Date:  2006-12-26

2.  Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production.

Authors:  Futoshi Matsui; Stephen K Babitz; Audrey Rhee; Karen L Hile; Hongji Zhang; Kirstan K Meldrum
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-19

3.  Extracellular matrix degradation and reduced neural density in children with intrinsic ureteropelvic junction obstruction.

Authors:  Cevdet Kaya; Guy Bogaert; Dirk de Ridder; Christian Schwentner; Helga Fritsch; Josef Oswald; Christian Radmayr
Journal:  Urology       Date:  2010-03-29       Impact factor: 2.649

4.  Urinary Emmprin, matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 as potential biomarkers in children with ureteropelvic junction narrowing on conservative treatment.

Authors:  Fengyan Tian; Chaohui Gu; Zhanzheng Zhao; Luping Li; Shan Lu; Zhenzhen Li
Journal:  Nephrology (Carlton)       Date:  2015-03       Impact factor: 2.506

Review 5.  Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy.

Authors:  Robert L Chevalier; Barbara A Thornhill; Michael S Forbes; Susan C Kiley
Journal:  Pediatr Nephrol       Date:  2009-10-21       Impact factor: 3.714

6.  Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology.

Authors:  S K Fernbach; M Maizels; J J Conway
Journal:  Pediatr Radiol       Date:  1993

7.  Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy.

Authors:  A K Sharma; S M Mauer; Y Kim; A F Michael
Journal:  J Lab Clin Med       Date:  1995-06

8.  Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis.

Authors:  E Engelmyer; H van Goor; D R Edwards; J R Diamond
Journal:  J Am Soc Nephrol       Date:  1995-03       Impact factor: 10.121

Review 9.  Matrix Metalloproteinases in Non-Neoplastic Disorders.

Authors:  Akinori Tokito; Michihisa Jougasaki
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

10.  MMP9 overexpression is associated with good surgical outcome in children with UPJO: Preliminary results.

Authors:  Sabrina Thalita Reis; Kátia R M Leite; Nayara Izabel Viana; Roberto Iglesias Lopes; Caio Martins Moura; Renato F Ivanovic; Marcos Machado; Francisco Tibor Denes; Amilcar Giron; William Carlos Nahas; Miguel Srougi; Carlo C Passerotti
Journal:  BMC Urol       Date:  2016-07-23       Impact factor: 2.264

View more
  1 in total

1.  The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.

Authors:  Antigoni Pavlaki; Nikoleta Printza; Evangelia Farmaki; Stella Stabouli; Anna Taparkou; Magdalini Sterpi; John Dotis; Fotios Papachristou
Journal:  Pediatr Nephrol       Date:  2019-10-13       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.